摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,6-二氯烟酸甲酯 | 65973-52-6

中文名称
4,6-二氯烟酸甲酯
中文别名
4,6-二氯吡啶-3-羧酸甲酯
英文名称
methyl 4,6-dichloropyridine-3-carboxylate
英文别名
methyl 4,6-dichloronicotinate;4,6-dichloro-nicotinic acid methyl ester;4,6-dichloropyridine-3-carboxylic acid methyl ester
4,6-二氯烟酸甲酯化学式
CAS
65973-52-6
化学式
C7H5Cl2NO2
mdl
MFCD04125732
分子量
206.028
InChiKey
JEJMDUMJSZTJTI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    41-43°
  • 沸点:
    260.0±35.0 °C(Predicted)
  • 密度:
    1.426±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    39.2
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xn
  • 安全说明:
    S24/25
  • 危险类别码:
    R22
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温

SDS

SDS:ee10f0319d99ab63036a819419cc838d
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Methyl 4,6-dichloronicotinate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H301: Toxic if swallowed
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
Avoid breathing dust/fume/gas/mist/vapours/spray
P261:
P280: Wear protective gloves/protective clothing/eye protection/face protection
P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P405: Store locked up

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 4,6-dichloronicotinate
CAS number: 65973-52-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H5Cl2NO2
Molecular weight: 206.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

甲壳素应用广泛,4,6-二氯烟酸甲酯可作为有机合成中间体和医药中间体,在实验室研发和化工生产中均有着重要的作用。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    4,6-二氯烟酸甲酯草酰氯N,N-二异丙基乙胺N,N-二甲基甲酰胺 、 lithium hydroxide 作用下, 以 乙醇 为溶剂, 反应 7.0h, 生成 6-chloro-4-(cyclopentylamino)-N-methylnicotinamide
    参考文献:
    名称:
    发现和基于结构的设计作为有效和选择性IRAK4抑制剂的4,6-二氨基烟酰胺
    摘要:
    识别用于治疗自身免疫性疾病的IRAK4的小分子抑制剂一直是研究的热点。我们发现了有效抑制IRAK4的新型4,6-二氨基烟酰胺。与IRAK4结合的抑制剂的X射线晶体结构有助于优化工作。结构活性关系(SAR)研究导致鉴定了在LTA刺激的细胞分析中表现出亚微摩尔效价的化合物29。
    DOI:
    10.1016/j.bmcl.2017.09.029
  • 作为产物:
    描述:
    参考文献:
    名称:
    一种新型4,6-二氯吡啶衍生物的简便合成,抗菌和抗氧化活性的生物学评估以及对接研究
    摘要:
    使用常规加热和无溶剂微波辐射技术,可以轻松合成新的4,6-二氯吡啶衍生物5(af),6(ac)和7(ac)。结果表明,后一种方法优于常规加热方法。产品操作简便,反应迅速和条件温和是该协议的显着特征。基于各种光谱方法对合成的化合物进行结构阐明。对合成的化合物进行体外评估使用琼脂良好扩散方法对各种微生物菌株的抗微生物活性(最低抑菌浓度; MIC)。在这些化合物中,5c对大多数使用的菌株表现出最佳的抗菌活性,尤其是对金黄色葡萄球菌,大肠杆菌,阿扎根霉和白色念珠菌。与其他化合物相比,化合物5a,6a,6c,7a和7c显示出显着的抗氧化活性。除此之外,还对高效化合物5a,6a进行了理论对接研究,6c,7a和7c对属于氧化还原酶家族的三个不同药物靶标的检测结果非常令人满意。
    DOI:
    10.1002/jccs.201600191
点击查看最新优质反应信息

文献信息

  • [EN] ARYL ETHER-BASE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASES DE TYPE ARYLÉTHER-BASE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2015038112A1
    公开(公告)日:2015-03-19
    The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
    本公开涉及一般可抑制AAK1(适配器相关激酶1)的化合物,包括这些化合物的组合物,以及抑制AAK1的方法。
  • IRAK DEGRADERS AND USES THEREOF
    申请人:Kymera Therapeutics, Inc.
    公开号:US20190192668A1
    公开(公告)日:2019-06-27
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用这些化合物的方法。
  • [EN] HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES<br/>[FR] SULFONES À HÉTÉROCYCLYLES À SUBSTITUTION HÉTÉROARYLE
    申请人:GRUENENTHAL GMBH
    公开号:WO2015158427A1
    公开(公告)日:2015-10-22
    The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    这项发明涉及芳基取代的杂环磺酮作为电压门控钙通道阻滞剂,以及含有这些化合物的药物组合物,还涉及这些化合物用于治疗和/或预防疼痛以及其他疾病和/或紊乱。
  • [EN] HETEROCYCLIC COMPOUNDS AS INHIBITORS OF HPK1<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE HPK1
    申请人:GUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD
    公开号:WO2021004547A1
    公开(公告)日:2021-01-14
    This disclosure relates to heterocyclics as inhibitors of HPK1, in particular relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising said compound that useful for treatment of HPK1 mediated diseases and conditions such as cancer. (I)
    这项披露涉及杂环化合物作为HPK1的抑制剂,特别涉及公式I的化合物或其药用盐,以及包含该化合物的药物组合物,用于治疗HPK1介导的疾病和状况,如癌症。 (I)
  • TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF
    申请人:Merck Patent GmbH
    公开号:US20160376283A1
    公开(公告)日:2016-12-29
    The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.
    本发明涉及式I化合物及其药用可接受的组合物,用作TBK/IKKε抑制剂
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-